Previous Article | Next Article ![]()
J. Virol., 05 1995, 2932-2945, Vol 69, No. 5
W Tan and S Schwartz
We have identified a sequence in the late 3' untranslated region of human
papillomavirus type 1 mRNAs that acts posttranscriptionally to repress gene
expression. Deletion analysis localized the inhibitory element to an
AU-rich sequence between nucleotides 6958 and 6984 on the human
papillomavirus type 1 genome. This sequence inhibits gene expression in an
orientation-dependent manner. Upon transfection of eucaryotic cells with
plasmids containing this sequence, approximately 4-fold-lower cytoplasmic
mRNA levels and 64- to 128-fold-lower protein levels were produced compared
with those produced by plasmids lacking the inhibitory sequence.
Interestingly, providing the constitutive transport element of simian
retrovirus type 1 in sense orientation counteracted inhibition exerted by
the human papillomavirus type 1 sequence. Inhibition could also be overcome
by the presence of human immunodeficiency virus type 1 Rev protein in trans
and its target sequence, the Rev-responsive element, in cis. Rev is a
nuclear protein and acts by promoting nuclear export of human
immunodeficiency virus type 1 mRNAs encoding structural proteins. Our
results are consistent with a model for human papillomavirus type 1
late-gene expression in which mRNAs containing human papillomavirus type 1
inhibitory sequences enter a nonproductive route in the nucleus, resulting
in inefficient mRNA utilization. Rev directs mRNA containing inhibitory
sequences to a productive route by interacting with the Rev-responsive
element.
Copyright © 1995, American Society for Microbiology
The Rev protein of human immunodeficiency virus type 1 counteracts the effect of an AU-rich negative element in the human papillomavirus type 1 late 3' untranslated region
Microbiology and Tumorbiology Center, Karolinska Institute, Stockholm, Sweden.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|